The investigators hypothesize that SCI patients using immersive IVR training will show improved reduction of neuropathic pain that will outlast the training sessions and transfers into daily life.
Neuropathic pain (NP) affects 40 to 70% of people with SCI and is a very disabling clinical condition. The definitions of NP as well as its neurophysiology are widely discussed in the literature. Many treatment options have been offered, but provide limited effects, leaving people with SCI with a reduced quality of life. Pain is a very complex experience that depends strongly on cognitive, emotional, and educational influences. Despite intensive investigations, the cause of neuropathic pain often remains unknown. A careful assessment of the pain including the use of tools to objectively measure pain will help with the diagnosis and the quantification of the damage. These tools include: 1) Laboratory testing that uses quantitative tests and measures objective responses in neurophysiology, sensory evoked potentials...etc.; 2) Quantitative sensory testing, that tests the perception of pain in response to external stimuli; 3) Bedside examination: physicians assessment on location, quality and intensity of pain; 4) Pain questionnaires, depending entirely on the subject's self-reported experience. When spinal cord injury occurs, the spinal somatosensory circuit is thought to generate aberrant nociceptive impulses that the brain interprets as pain. Thalamic circuits may also serve as amplifiers of nociceptive signals. Sensory deafferentation after injury to the spinal cord produces extensive and long-lasting reorganization of the cortical and subcortical sensory maps. It has been suggested that pain and phantom limb sensations are the consequence of those cortical plasticity change. Therefore, strategies aimed at reversing or modulating the somatosensory neural reorganization may be valuable alternative approaches to neuropathic pain. Immersive virtual reality (IVR) is an emerging approach to the treatment of neuropathic pain conditions in SCI. Despite promising initial studies, IVR therapy has not yet been made widely available to individuals with SCI, because equipment is expensive and can be difficult for clinicians to use, especially those with limited experience with technology. However, with the development of 'plug and play', low-cost IVR devices such as the Oculus Rift, Gear VR and Google Cardboard, IVR no longer requires such specific technical knowledge. As a result, IVR is now a feasible and affordable treatment option for neuropathic pain. The investigators believe that IVR neurorehabilitation exploits the idea of inducing activation in action observation, motor imagery, and processing systems, which in turn, should activate downstream cortical areas involved in movement and motor imagery. Also, perturbations of the somatosensory system associated with central pain can be reversed or modulated by employing motor imagery and related task execution combined with visual illusions. The investigators hypothesize that SCI patients using immersive IVR training will show improved reduction of neuropathic pain that will outlast the training sessions and transfers into daily life.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
Immersing the user in a total visual environment.
Burke Medical Research Institute
White Plains, New York, United States
Change in Neuropathic Pain Scale
It includes 11 items, assessing global pain intensity, unpleasantness, and one item which allows the patient to describe the temporal aspects of their pain and its qualities in their own words. The remaining 8 items assess specific NP qualities: "Sharp," "Hot," "Dull," "Cold," "Sensitive," "Itchy," "Deep," and "Surface." This is a sensitive tool for measuring changes in neuropathic pain after a therapeutic intervention.
Time frame: Baseline compared with immediately after intervention, and 1 month follow up
Upper Extremity Motor Score (UEMS)
Clinical measure of motor strength
Time frame: Baseline, immediately after intervention, and 1 month follow up
Modified Ashworth Scale
Measure of spasticity scored from 1 (no increase in tone) to 4 (rigid limb)
Time frame: Baseline, immediately after intervention, and 1 month follow up
Spinal Cord Independence Measure (SCIM III)
Measures patient's ability to complete activities of daily living
Time frame: Baseline, immediately after intervention, and 1 month follow up
Beck Depression Inventory
Self-report measuring characteristic attitudes and symptoms of depression
Time frame: Baseline, immediately after intervention, and 1 month follow up
Immersive Tendencies Questionnaire (ITQ)
Measures an individual's sense of engagement and involvement in an activity
Time frame: Baseline, immediately after intervention, and 1 month follow up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Presence Questionnaire
Measure of presence (ex: selective attention, involvement, immersive response, etc)
Time frame: Baseline, post-intervention, and 1 month follow up
Patient's Global Impression of Change
Evaluates both motor function and pain with no change (score 0-1), minimally improved (score 2-3), much improved (score 4-5), and very much improved (score 6-7).
Time frame: Baseline, immediately after intervention, and 1 month follow up
Transcranial Magnetic Stimulation
Assess brain reorganization, output and responsiveness as determined by motor threshold, motor evoked potential and amplitude of response.
Time frame: Baseline, immediately after intervention, and 1 month follow up